StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $184.19M, up 7.5% from the year before. The highest annual figure on record is $210.83M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$184.19M+7.5%
FY2024Dec 31, 2024$171.31M-18.7%
FY2023Dec 31, 2023$210.83M+16.7%
FY2022Dec 31, 2022$180.62M-5.4%
FY2021Dec 31, 2021$191.01M+29.0%
FY2020Dec 31, 2020$148.07M–

More Alvotech figures

See a number that looks wrong?